US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Replimune Group Inc.

12.85

-0.3950-2.98%

Volume:1.56M

Turnover:19.80M

Market Cap:1.21B

PE:-4.07

High:13.74

Open:13.33

Low:12.40

Close:13.24

52wk High:16.33

52wk Low:1.50

Shares:94.22M

Float Shares:77.49M

Volume Ratio:2.77

T/O Rate:2.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.1550

EPS(LYR):-3.3828

ROE:-134.29%

ROA:-51.30%

PB:11.46

PE(LYR):-3.80

Loading ...

Overview Company News Filings

Replimune presents 3-year overall survival data from IGNYTE trial

Replimune publishes RP2 Phase 1 ASCO presentation data###

Replimune says RP2 plus nivolumab posts 19.1% response rate in phase 1 advanced solid tumor trial

Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Replimune Group - Rp1 Plus Nivolumab Achieves Median Overall Survival of 32.9 Months in Anti-Pd-1-Failed Melanoma

THOMSON REUTERS

Replimune reports 32.9-month median survival in IGNYTE trial of RP1-nivolumab in anti-PD-1-failed melanoma

Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Top News Today: Stocks Rise as Traders Await Iran Deal Confirmation

Wedbush Adjusts Price Target on Replimune Group to $6 From $2, Maintains Neutral Rating

MT Newswires Live

Top Midday Gainers

MT Newswires Live

Why Penny Stock Replimune (REPL) Nearly Doubled Today

Replimune Shares Soar as FDA Reverses Course on Skin Cancer Drug Application

Replimune Shares Surge 75% After Co Plans to Resubmit US Application for Skin Cancer Drug

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, Replimune

Market Chatter: Replimune Plans to Resubmit Melanoma Therapy Application for FDA Approval

MT Newswires Live

Replimune Gets Third Try at FDA Approval After Makary Departure -- Update

Replimune plans RP1 melanoma BLA resubmission after FDA talks

Replimune reaches agreement with US FDA to resubmit melanoma drug application

Replimune Announces Planned Rp1 Bla Resubmission Following Productive Discussion With FDA

THOMSON REUTERS

Replimune Group - to Resubmit Rp1 Bla for Advanced Melanoma After Alignment With FDA

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/REPL/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"REPL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPL\",,,,,undefined,":{"symbol":"REPL","market":"US","secType":"STK","nameCN":"Replimune Group Inc.","latestPrice":12.845,"timestamp":1789141092945,"preClose":13.24,"halted":0,"volume":1555638,"delay":0,"changeRate":-0.02983383685800601,"floatShares":77485633,"shares":94219634,"eps":-3.154987,"marketStatus":"Trading","change":-0.395,"latestTime":"09-11 11:38:14 EDT","open":13.33,"high":13.74,"low":12.4,"amount":19802584.148004003,"amplitude":0.101208,"askPrice":12.85,"askSize":171,"bidPrice":12.83,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-3.154987,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1532059200000,"exchange":"NASDAQ","adjPreClose":13.24,"preHourTrading":{"tag":"盘前","latestPrice":13.4,"preClose":13.24,"latestTime":"09:15 EDT","volume":375,"amount":5020.753874999999,"timestamp":1789132556205,"change":0.16,"changeRate":0.012085,"amplitude":0.012085},"postHourTrading":{"tag":"盘后","latestPrice":13.3,"preClose":13.24,"latestTime":"19:52 EDT","volume":37238,"amount":493266.0147,"timestamp":1789084330868,"change":0.06,"changeRate":0.004532,"amplitude":0.013595},"volumeRatio":2.772822,"impliedVol":0.8523,"impliedVolPercentile":0.1315},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPL\",,,,,undefined,":{"symbol":"REPL","floatShares":77485633,"roa":"-51.30%","roe":"-134.29%","lyrEps":-3.382838,"volumeRatio":2.772822,"shares":94219634,"dividePrice":0,"high":13.74,"amplitude":0.101208,"preClose":13.24,"low":12.4,"week52Low":1.5,"pbRate":"11.46","week52High":16.33,"institutionHeld":0,"latestPrice":12.845,"committee":0.707942,"eps":-3.154987,"divideRate":0,"volume":1555638,"delay":0,"ttmEps":-3.154987,"open":13.33,"prevYearClose":9.72,"prevWeekClose":15.04,"prevMonthClose":15.3,"prevQuarterClose":11.07,"fiveDayClose":15.29,"twentyDayClose":15.19,"sixtyDayClose":8.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REPL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"REPL","fiscalQuarterEnding":"2026/06","expectedEps":-0.72,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-0.72},{"market":"US","date":"2026-06-29","symbol":"REPL","fiscalQuarterEnding":"2026/03","expectedEps":-0.73,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1782705600000,"reportTimeType":"pre","actualEps":-0.76},{"market":"US","date":"2026-02-03","symbol":"REPL","fiscalQuarterEnding":"2025/12","expectedEps":-0.85,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770094800000,"reportTimeType":"pre","actualEps":-0.77},{"market":"US","date":"2025-11-06","symbol":"REPL","fiscalQuarterEnding":"2025/09","expectedEps":-0.87,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2025-08-07","symbol":"REPL","fiscalQuarterEnding":"2025/06","expectedEps":-0.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REPL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REPL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.4444,"hold":0,"sell":0.1111,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4444,"analysts":9,"updateTime":1785816000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REPL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REPL","date":"2026-09-10","current":-4.071332,"percent":0.461603,"low":-17.365275,"twenty":-7.444915,"median":-3.936989,"eighty":-2.258937,"high":-0.445838,"avg":-5.220289,"sd":3.641871,"marketCap":1361473711},"quantilePoints":[{"date":"2021-09-17","current":-16.803109,"twenty":-21.82081,"median":-16.215155,"eighty":-13.475095,"marketCap":1523840328},{"date":"2021-09-24","current":-16.638069,"twenty":-21.723491,"median":-16.238363,"eighty":-13.488815,"marketCap":1508873204},{"date":"2021-10-01","current":-15.240389,"twenty":-21.67427,"median":-16.219027,"eighty":-13.513752,"marketCap":1382120371},{"date":"2021-10-08","current":-15.972753,"twenty":-21.626019,"median":-16.19167,"eighty":-13.533427,"marketCap":1448536985},{"date":"2021-10-15","current":-15.549838,"twenty":-21.540653,"median":-16.15388,"eighty":-13.565594,"marketCap":1410183729},{"date":"2021-10-22","current":-14.961884,"twenty":-21.492962,"median":-16.14312,"eighty":-13.567208,"marketCap":1356863349},{"date":"2021-10-29","current":-15.219759,"twenty":-21.476079,"median":-16.139261,"eighty":-13.574656,"marketCap":1380249481},{"date":"2021-11-05","current":-15.694027,"twenty":-21.451576,"median":-16.135948,"eighty":-13.594071,"marketCap":1568586638},{"date":"2021-11-12","current":-15.689335,"twenty":-21.392191,"median":-16.126343,"eighty":-13.624185,"marketCap":1568117703},{"date":"2021-11-19","current":-16.06937,"twenty":-21.266207,"median":-16.114408,"eighty":-13.633329,"marketCap":1606101416},{"date":"2021-11-26","current":-13.606182,"twenty":-21.237353,"median":-16.104262,"eighty":-13.632281,"marketCap":1359910688},{"date":"2021-12-03","current":-12.977483,"twenty":-21.223934,"median":-16.091557,"eighty":-13.587048,"marketCap":1297073435},{"date":"2021-12-10","current":-12.907106,"twenty":-21.205376,"median":-16.076662,"eighty":-13.56612,"marketCap":1290039414},{"date":"2021-12-17","current":-12.311249,"twenty":-21.124959,"median":-16.069894,"eighty":-13.48331,"marketCap":1230484705},{"date":"2021-12-23","current":-13.517038,"twenty":-21.122485,"median":-16.044742,"eighty":-13.433519,"marketCap":1351000928},{"date":"2021-12-31","current":-12.714743,"twenty":-21.069904,"median":-16.015764,"eighty":-13.41643,"marketCap":1270813091},{"date":"2022-01-07","current":-12.189262,"twenty":-21.03217,"median":-16.010593,"eighty":-13.380684,"marketCap":1218292402},{"date":"2022-01-14","current":-11.199295,"twenty":-21.025984,"median":-15.986212,"eighty":-13.311118,"marketCap":1119347176},{"date":"2022-01-21","current":-9.74015,"twenty":-21.006293,"median":-15.955897,"eighty":-13.293375,"marketCap":973508478},{"date":"2022-01-28","current":-8.731415,"twenty":-20.94976,"median":-15.905705,"eighty":-13.286213,"marketCap":872687513},{"date":"2022-02-04","current":-7.99328,"twenty":-20.910732,"median":-15.895098,"eighty":-13.233597,"marketCap":861987330},{"date":"2022-02-11","current":-7.673724,"twenty":-20.897089,"median":-15.869823,"eighty":-13.195305,"marketCap":827526719},{"date":"2022-02-18","current":-7.047744,"twenty":-20.882104,"median":-15.845206,"eighty":-13.132121,"marketCap":760021687},{"date":"2022-02-25","current":-7.183446,"twenty":-20.847524,"median":-15.829866,"eighty":-13.09789,"marketCap":774655645},{"date":"2022-03-04","current":-6.728188,"twenty":-20.805093,"median":-15.823685,"eighty":-13.048554,"marketCap":725561076},{"date":"2022-03-11","current":-7.157181,"twenty":-20.790794,"median":-15.81014,"eighty":-12.996831,"marketCap":771823266},{"date":"2022-03-18","current":-7.179069,"twenty":-20.744594,"median":-15.804542,"eighty":-12.973236,"marketCap":774183582},{"date":"2022-03-25","current":-6.999592,"twenty":-20.701197,"median":-15.776661,"eighty":-12.940996,"marketCap":754828992},{"date":"2022-04-01","current":-7.99328,"twenty":-20.631971,"median":-15.738739,"eighty":-12.832728,"marketCap":861987330},{"date":"2022-04-08","current":-8.5142,"twenty":-20.531056,"median":-15.706391,"eighty":-12.758307,"marketCap":918162846},{"date":"2022-04-14","current":-7.774406,"twenty":-20.522449,"median":-15.696716,"eighty":-12.748252,"marketCap":838384172},{"date":"2022-04-22","current":-8.01079,"twenty":-20.493993,"median":-15.689335,"eighty":-12.730018,"marketCap":863875582},{"date":"2022-04-29","current":-7.341035,"twenty":-20.416327,"median":-15.662226,"eighty":-12.654887,"marketCap":791649919},{"date":"2022-05-06","current":-6.452407,"twenty":-20.38299,"median":-15.655671,"eighty":-12.538835,"marketCap":695821097},{"date":"2022-05-13","current":-6.491804,"twenty":-20.292997,"median":-15.6402,"eighty":-12.449348,"marketCap":700069666},{"date":"2022-05-20","current":-6.148507,"twenty":-20.245319,"median":-15.637726,"eighty":-12.395603,"marketCap":725745226},{"date":"2022-05-27","current":-6.235809,"twenty":-20.234774,"median":-15.631638,"eighty":-12.379449,"marketCap":736049925},{"date":"2022-06-03","current":-6.809503,"twenty":-20.212392,"median":-15.622317,"eighty":-12.311955,"marketCap":803766518},{"date":"2022-06-10","current":-6.468612,"twenty":-20.203255,"median":-15.607654,"eighty":-12.134279,"marketCap":763529122},{"date":"2022-06-17","current":-6.318953,"twenty":-20.189959,"median":-15.595469,"eighty":-11.992537,"marketCap":745863924},{"date":"2022-06-24","current":-7.699145,"twenty":-20.143355,"median":-15.58377,"eighty":-11.944204,"marketCap":908776307},{"date":"2022-07-01","current":-7.640944,"twenty":-20.124611,"median":-15.580646,"eighty":-11.881776,"marketCap":901906508},{"date":"2022-07-08","current":-8.79249,"twenty":-20.103951,"median":-15.560153,"eighty":-11.848266,"marketCap":1037830394},{"date":"2022-07-15","current":-8.534744,"twenty":-20.061997,"median":-15.550705,"eighty":-11.726024,"marketCap":1007406997},{"date":"2022-07-22","current":-7.782289,"twenty":-20.016455,"median":-15.527958,"eighty":-11.633525,"marketCap":918590306},{"date":"2022-07-29","current":-8.053709,"twenty":-19.98877,"median":-15.522807,"eighty":-11.543915,"marketCap":950627642},{"date":"2022-08-05","current":-7.601167,"twenty":-19.981078,"median":-15.512904,"eighty":-11.450611,"marketCap":1010788047},{"date":"2022-08-12","current":-7.515886,"twenty":-19.970963,"median":-15.503521,"eighty":-11.34073,"marketCap":999447498},{"date":"2022-08-19","current":-7.145097,"twenty":-19.933441,"median":-15.494489,"eighty":-11.242484,"marketCap":950140764},{"date":"2022-08-26","current":-7.108019,"twenty":-19.888487,"median":-15.449739,"eighty":-11.188671,"marketCap":945210090},{"date":"2022-09-02","current":-6.993074,"twenty":-19.816752,"median":-15.442937,"eighty":-10.953866,"marketCap":929925003},{"date":"2022-09-09","current":-6.80768,"twenty":-19.756813,"median":-15.436976,"eighty":-10.890541,"marketCap":905271636},{"date":"2022-09-16","current":-6.110597,"twenty":-19.689634,"median":-15.431329,"eighty":-10.778331,"marketCap":812574976},{"date":"2022-09-23","current":-5.888124,"twenty":-19.622483,"median":-15.403136,"eighty":-10.685646,"marketCap":782990935},{"date":"2022-09-30","current":-6.40352,"twenty":-19.571492,"median":-15.3916,"eighty":-10.533097,"marketCap":851527296},{"date":"2022-10-07","current":-6.407228,"twenty":-19.534008,"median":-15.373891,"eighty":-10.386415,"marketCap":852020363},{"date":"2022-10-14","current":-6.918916,"twenty":-19.530951,"median":-15.351275,"eighty":-10.014098,"marketCap":920063656},{"date":"2022-10-21","current":-7.104311,"twenty":-19.514142,"median":-15.301721,"eighty":-9.807604,"marketCap":944717023},{"date":"2022-10-28","current":-6.700151,"twenty":-19.463693,"median":-15.295377,"eighty":-9.668193,"marketCap":890972683},{"date":"2022-11-04","current":-6.285013,"twenty":-19.412753,"median":-15.286558,"eighty":-9.346952,"marketCap":922168605},{"date":"2022-11-11","current":-7.118947,"twenty":-19.397565,"median":-15.277234,"eighty":-9.233032,"marketCap":1044527547},{"date":"2022-11-18","current":-6.451122,"twenty":-19.391261,"median":-15.249135,"eighty":-9.01396,"marketCap":946540915},{"date":"2022-11-25","current":-6.77656,"twenty":-19.371343,"median":-15.242339,"eighty":-8.798362,"marketCap":994290745},{"date":"2022-12-02","current":-6.888429,"twenty":-19.304205,"median":-15.235232,"eighty":-8.708895,"marketCap":1010704750},{"date":"2022-12-09","current":-9.390679,"twenty":-19.279831,"median":-15.219759,"eighty":-8.63141,"marketCap":1377847325},{"date":"2022-12-16","current":-10.475589,"twenty":-19.272597,"median":-15.211631,"eighty":-8.66615,"marketCap":1537030766},{"date":"2022-12-23","current":-10.317569,"twenty":-19.263359,"median":-15.167534,"eighty":-8.683543,"marketCap":1513845240},{"date":"2022-12-30","current":-10.483297,"twenty":-19.232063,"median":-15.140954,"eighty":-8.703265,"marketCap":1538161768},{"date":"2023-01-06","current":-9.951424,"twenty":-19.172861,"median":-15.102526,"eighty":-8.725785,"marketCap":1460122678},{"date":"2023-01-13","current":-10.814754,"twenty":-19.157758,"median":-15.094278,"eighty":-8.739746,"marketCap":1586794823},{"date":"2023-01-20","current":-10.571943,"twenty":-19.139105,"median":-15.069399,"eighty":-8.744456,"marketCap":1551168282},{"date":"2023-01-27","current":-9.978403,"twenty":-19.098984,"median":-15.054481,"eighty":-8.773977,"marketCap":1464081182},{"date":"2023-02-03","current":-10.9034,"twenty":-19.078394,"median":-15.010475,"eighty":-8.810107,"marketCap":1599801338},{"date":"2023-02-10","current":-9.011098,"twenty":-19.073536,"median":-14.978305,"eighty":-8.917906,"marketCap":1412408501},{"date":"2023-02-17","current":-8.971338,"twenty":-19.066387,"median":-14.977232,"eighty":-8.826962,"marketCap":1406176454},{"date":"2023-02-24","current":-7.156829,"twenty":-19.047944,"median":-14.961884,"eighty":-8.755293,"marketCap":1121768485},{"date":"2023-03-03","current":-7.96649,"twenty":-18.994109,"median":-14.946412,"eighty":-8.688473,"marketCap":1248675626},{"date":"2023-03-10","current":-6.741154,"twenty":-18.947558,"median":-14.924413,"eighty":-8.617499,"marketCap":1056615265},{"date":"2023-03-17","current":-7.084537,"twenty":-18.937613,"median":-14.892132,"eighty":-8.574334,"marketCap":1110437490},{"date":"2023-03-24","current":-7.1496,"twenty":-18.918827,"median":-14.820632,"eighty":-8.464903,"marketCap":1120635385},{"date":"2023-03-31","current":-6.383313,"twenty":-18.90696,"median":-14.796136,"eighty":-8.404346,"marketCap":1000526840},{"date":"2023-04-06","current":-5.967638,"twenty":-18.893903,"median":-14.769731,"eighty":-8.353404,"marketCap":935373620},{"date":"2023-04-14","current":-5.880889,"twenty":-18.876593,"median":-14.754647,"eighty":-8.240934,"marketCap":921776426},{"date":"2023-04-21","current":-6.014628,"twenty":-18.872042,"median":-14.72342,"eighty":-8.237923,"marketCap":942738767},{"date":"2023-04-28","current":-6.058002,"twenty":-18.865271,"median":-14.673543,"eighty":-8.162132,"marketCap":949537364},{"date":"2023-05-05","current":-6.307407,"twenty":-18.84001,"median":-14.642657,"eighty":-8.111975,"marketCap":988629296},{"date":"2023-05-12","current":-6.773685,"twenty":-18.786092,"median":-14.624593,"eighty":-8.085208,"marketCap":1061714212},{"date":"2023-05-18","current":-6.338918,"twenty":-18.760756,"median":-14.598129,"eighty":-8.043545,"marketCap":1104771993},{"date":"2023-05-26","current":-6.368208,"twenty":-18.750284,"median":-14.595028,"eighty":-8.000284,"marketCap":1109876825},{"date":"2023-06-02","current":-6.12621,"twenty":-18.73441,"median":-14.58914,"eighty":-7.976597,"marketCap":1067700350},{"date":"2023-06-09","current":-7.47875,"twenty":-18.702219,"median":-14.527689,"eighty":-7.936373,"marketCap":1303426402},{"date":"2023-06-16","current":-7.962747,"twenty":-18.69597,"median":-14.518235,"eighty":-7.928773,"marketCap":1387779351},{"date":"2023-06-23","current":-7.796994,"twenty":-18.685243,"median":-14.453528,"eighty":-7.888232,"marketCap":1358891355},{"date":"2023-06-30","current":-7.661077,"twenty":-18.667244,"median":-14.399755,"eighty":-7.855942,"marketCap":1335203198},{"date":"2023-07-07","current":-7.004698,"twenty":-18.652142,"median":-14.394793,"eighty":-7.843896,"marketCap":1220806732},{"date":"2023-07-14","current":-6.78922,"twenty":-18.6103,"median":-14.376721,"eighty":-7.822971,"marketCap":1183252336},{"date":"2023-07-21","current":-6.80248,"twenty":-18.564048,"median":-14.344533,"eighty":-7.779136,"marketCap":1185563376},{"date":"2023-07-28","current":-6.594113,"twenty":-18.408435,"median":-14.24963,"eighty":-7.705572,"marketCap":1149248430},{"date":"2023-08-04","current":-6.255847,"twenty":-18.227267,"median":-14.198296,"eighty":-7.665176,"marketCap":1135974257},{"date":"2023-08-11","current":-6.335446,"twenty":-18.127797,"median":-14.118082,"eighty":-7.647887,"marketCap":1150428357},{"date":"2023-08-18","current":-6.198991,"twenty":-17.947873,"median":-14.068648,"eighty":-7.573533,"marketCap":1125649900},{"date":"2023-08-25","current":-6.6311,"twenty":-17.81854,"median":-14.004724,"eighty":-7.50913,"marketCap":1204115013},{"date":"2023-09-01","current":-6.634349,"twenty":-17.717437,"median":-13.953723,"eighty":-7.465927,"marketCap":1204704976},{"date":"2023-09-08","current":-6.367936,"twenty":-17.631427,"median":-13.917117,"eighty":-7.434714,"marketCap":1156327989},{"date":"2023-09-15","current":-6.013801,"twenty":-17.579267,"median":-13.810922,"eighty":-7.397943,"marketCap":1092021994},{"date":"2023-09-28","current":-5.393252,"twenty":-17.366758,"median":-13.743606,"eighty":-7.371559,"marketCap":979339011},{"date":"2023-10-06","current":-5.234053,"twenty":-17.358495,"median":-13.711323,"eighty":-7.341615,"marketCap":950430811},{"date":"2023-10-13","current":-4.792197,"twenty":-17.358973,"median":-13.704061,"eighty":-7.315646,"marketCap":870195808},{"date":"2023-10-19","current":-4.649243,"twenty":-17.359211,"median":-13.6531,"eighty":-7.277231,"marketCap":844237425},{"date":"2023-10-23","current":-4.821437,"twenty":-17.35945,"median":-13.643461,"eighty":-7.266629,"marketCap":875505477},{"date":"2023-10-31","current":-4.6265,"twenty":-17.364158,"median":-13.606182,"eighty":-7.244347,"marketCap":840107682},{"date":"2023-11-10","current":-3.415142,"twenty":-17.32282,"median":-13.521228,"eighty":-7.181695,"marketCap":678001257},{"date":"2023-11-17","current":-3.070058,"twenty":-17.327339,"median":-13.433519,"eighty":-7.15697,"marketCap":609492419},{"date":"2023-11-24","current":-3.090882,"twenty":-17.327339,"median":-13.422358,"eighty":-7.134315,"marketCap":613626573},{"date":"2023-12-01","current":-3.325896,"twenty":-17.327339,"median":-13.311118,"eighty":-7.115651,"marketCap":660283454},{"date":"2023-12-08","current":-2.260895,"twenty":-17.32282,"median":-13.291275,"eighty":-7.101345,"marketCap":448851006},{"date":"2023-12-15","current":-2.308493,"twenty":-17.32282,"median":-13.255017,"eighty":-7.080326,"marketCap":458300501},{"date":"2023-12-22","current":-2.290644,"twenty":-17.32282,"median":-13.177521,"eighty":-7.039837,"marketCap":454756941},{"date":"2023-12-29","current":-2.555407,"twenty":-17.327339,"median":-13.141695,"eighty":-7.025096,"marketCap":507319756},{"date":"2024-01-05","current":-2.620854,"twenty":-17.331857,"median":-13.153424,"eighty":-7.015385,"marketCap":520312811},{"date":"2024-01-12","current":-2.620854,"twenty":-17.331857,"median":-13.153424,"eighty":-6.998149,"marketCap":520312811},{"date":"2024-01-19","current":-2.27577,"twenty":-17.336375,"median":-13.165154,"eighty":-6.976101,"marketCap":451803973},{"date":"2024-01-26","current":-2.347166,"twenty":-17.331857,"median":-13.153424,"eighty":-6.953227,"marketCap":465978216},{"date":"2024-02-02","current":-2.338242,"twenty":-17.331857,"median":-13.131353,"eighty":-6.92926,"marketCap":464206435},{"date":"2024-02-09","current":-2.257183,"twenty":-17.331857,"median":-13.069432,"eighty":-6.885152,"marketCap":473913707},{"date":"2024-02-16","current":-2.23964,"twenty":-17.304882,"median":-13.00772,"eighty":-6.857169,"marketCap":470230440},{"date":"2024-02-23","current":-2.324431,"twenty":-17.304882,"median":-12.978804,"eighty":-6.834348,"marketCap":488032898},{"date":"2024-03-01","current":-2.508631,"twenty":-17.29598,"median":-12.943915,"eighty":-6.80768,"marketCap":526707203},{"date":"2024-03-08","current":-2.58465,"twenty":-17.29598,"median":-12.874263,"eighty":-6.789321,"marketCap":542668028},{"date":"2024-03-15","current":-2.58465,"twenty":-17.29598,"median":-12.874263,"eighty":-6.773685,"marketCap":542668028},{"date":"2024-03-22","current":-2.397526,"twenty":-17.29598,"median":-12.760313,"eighty":-6.739451,"marketCap":503379845},{"date":"2024-03-28","current":-2.412145,"twenty":-17.29598,"median":-12.747585,"eighty":-6.71682,"marketCap":506449234},{"date":"2024-04-05","current":-2.146078,"twenty":-17.304882,"median":-12.701477,"eighty":-6.680523,"marketCap":450586349},{"date":"2024-04-12","current":-2.102221,"twenty":-17.261345,"median":-12.582004,"eighty":-6.649243,"marketCap":441378181},{"date":"2024-04-19","current":-2.037897,"twenty":-17.261345,"median":-12.418128,"eighty":-6.619319,"marketCap":427872868},{"date":"2024-04-26","current":-1.798145,"twenty":-17.253415,"median":-12.311955,"eighty":-6.599292,"marketCap":377534883},{"date":"2024-05-03","current":-1.918021,"twenty":-17.253415,"median":-12.073728,"eighty":-6.568396,"marketCap":402703876},{"date":"2024-05-10","current":-1.967726,"twenty":-17.253415,"median":-11.686636,"eighty":-6.523016,"marketCap":413139799},{"date":"2024-05-17","current":-1.912516,"twenty":-17.253415,"median":-11.471468,"eighty":-6.489603,"marketCap":412709505},{"date":"2024-05-24","current":-1.610839,"twenty":-17.253415,"median":-11.245895,"eighty":-6.455856,"marketCap":347609494},{"date":"2024-05-31","current":-1.451463,"twenty":-17.253415,"median":-11.199295,"eighty":-6.429551,"marketCap":313217035},{"date":"2024-06-07","current":-2.02351,"twenty":-17.253415,"median":-11.019024,"eighty":-6.403667,"marketCap":436661396},{"date":"2024-06-14","current":-2.692322,"twenty":-17.261345,"median":-10.931572,"eighty":-6.396942,"marketCap":580986893},{"date":"2024-06-21","current":-2.239807,"twenty":-17.269275,"median":-10.852478,"eighty":-6.368208,"marketCap":483336876},{"date":"2024-06-28","current":-2.424797,"twenty":-17.29598,"median":-10.804126,"eighty":-6.362258,"marketCap":523256694},{"date":"2024-07-05","current":-2.302419,"twenty":-17.29598,"median":-10.763984,"eighty":-6.338722,"marketCap":496848199},{"date":"2024-07-12","current":-2.823238,"twenty":-17.29598,"median":-10.704911,"eighty":-6.326195,"marketCap":609237841},{"date":"2024-07-15","current":-2.948462,"twenty":-17.29598,"median":-10.672408,"eighty":-6.321564,"marketCap":636260487},{"date":"2024-08-02","current":-3.2357,"twenty":-17.360806,"median":-10.556526,"eighty":-6.30697,"marketCap":698244667},{"date":"2024-08-09","current":-2.934568,"twenty":-17.360806,"median":-10.481741,"eighty":-6.280817,"marketCap":645637192},{"date":"2024-08-16","current":-3.198524,"twenty":-17.360806,"median":-10.336007,"eighty":-6.231015,"marketCap":703710378},{"date":"2024-08-23","current":-3.148838,"twenty":-17.360806,"median":-10.221215,"eighty":-6.160784,"marketCap":692778955},{"date":"2024-08-30","current":-3.434531,"twenty":-17.360806,"median":-10.111004,"eighty":-6.142122,"marketCap":755634639},{"date":"2024-09-06","current":-3.328949,"twenty":-17.360806,"median":-10.055486,"eighty":-6.110199,"marketCap":732405365},{"date":"2024-09-13","current":-3.223367,"twenty":-17.360806,"median":-9.951424,"eighty":-6.072015,"marketCap":709176090},{"date":"2024-09-20","current":-3.487322,"twenty":-17.360806,"median":-9.824237,"eighty":-6.050554,"marketCap":767249277},{"date":"2024-09-27","current":-3.456269,"twenty":-17.341038,"median":-9.672861,"eighty":-6.031978,"marketCap":760417137},{"date":"2024-10-04","current":-3.630169,"twenty":-17.341038,"median":-9.390679,"eighty":-5.972448,"marketCap":798677119},{"date":"2024-10-11","current":-3.453163,"twenty":-17.341038,"median":-9.226291,"eighty":-5.909884,"marketCap":759733923},{"date":"2024-10-18","current":-3.512165,"twenty":-17.341038,"median":-9.011098,"eighty":-5.876626,"marketCap":772714988},{"date":"2024-10-25","current":-3.714014,"twenty":-17.341038,"median":-8.90989,"eighty":-5.795064,"marketCap":817123896},{"date":"2024-10-31","current":-3.760594,"twenty":-17.341038,"median":-8.768922,"eighty":-5.525809,"marketCap":827372105},{"date":"2024-11-08","current":-3.791648,"twenty":-17.205109,"median":-8.678585,"eighty":-5.069007,"marketCap":834204245},{"date":"2024-11-15","current":-3.661401,"twenty":-17.192664,"median":-8.604536,"eighty":-4.715521,"marketCap":779958861},{"date":"2024-11-22","current":-3.548989,"twenty":-17.192664,"median":-8.493293,"eighty":-3.820091,"marketCap":756012756},{"date":"2024-11-29","current":-4.522151,"twenty":-17.192664,"median":-8.424021,"eighty":-3.820091,"marketCap":963317611},{"date":"2024-12-06","current":-4.615452,"twenty":-17.192664,"median":-8.333153,"eighty":-3.820091,"marketCap":983192794},{"date":"2024-12-13","current":-4.321902,"twenty":-17.192664,"median":-8.240025,"eighty":-3.820091,"marketCap":920660225},{"date":"2024-12-20","current":-4.24763,"twenty":-17.192664,"median":-8.201035,"eighty":-3.820091,"marketCap":904838732},{"date":"2024-12-27","current":-4.523497,"twenty":-17.192664,"median":-8.13773,"eighty":-3.820091,"marketCap":963604278},{"date":"2025-01-03","current":-4.537396,"twenty":-17.192664,"median":-8.078641,"eighty":-3.820091,"marketCap":966565111},{"date":"2025-01-10","current":-4.1653,"twenty":-17.196713,"median":-8.023922,"eighty":-3.817856,"marketCap":887300616},{"date":"2025-01-17","current":-3.742629,"twenty":-17.078146,"median":-7.988903,"eighty":-3.790414,"marketCap":797262305},{"date":"2025-01-24","current":-4.967292,"twenty":-16.990879,"median":-7.962747,"eighty":-3.774419,"marketCap":1058142538},{"date":"2025-01-31","current":-4.920329,"twenty":-16.953236,"median":-7.899761,"eighty":-3.774419,"marketCap":1048138282},{"date":"2025-02-07","current":-5.079282,"twenty":-16.830086,"median":-7.844848,"eighty":-3.774419,"marketCap":1081998843},{"date":"2025-02-14","current":-4.821817,"twenty":-16.78929,"median":-7.805048,"eighty":-3.774419,"marketCap":1100541220},{"date":"2025-02-21","current":-4.828566,"twenty":-16.78929,"median":-7.774406,"eighty":-3.774419,"marketCap":1102081516},{"date":"2025-02-28","current":-4.263377,"twenty":-16.78929,"median":-7.699145,"eighty":-3.774419,"marketCap":973081757},{"date":"2025-03-07","current":-3.961381,"twenty":-16.791042,"median":-7.658931,"eighty":-3.769362,"marketCap":904153528},{"date":"2025-03-14","current":-4.001872,"twenty":-16.791042,"median":-7.643303,"eighty":-3.761336,"marketCap":913395302},{"date":"2025-03-21","current":-3.914141,"twenty":-16.791042,"median":-7.573195,"eighty":-3.761336,"marketCap":893371459},{"date":"2025-03-28","current":-3.526102,"twenty":-16.791042,"median":-7.503948,"eighty":-3.734509,"marketCap":804804461},{"date":"2025-04-04","current":-2.662291,"twenty":-16.791042,"median":-7.445715,"eighty":-3.714635,"marketCap":607646622},{"date":"2025-04-11","current":-2.334988,"twenty":-16.78929,"median":-7.411075,"eighty":-3.662101,"marketCap":532942284},{"date":"2025-04-17","current":-2.57456,"twenty":-16.78929,"median":-7.377317,"eighty":-3.643832,"marketCap":587622779},{"date":"2025-04-25","current":-3.057079,"twenty":-16.791042,"median":-7.330201,"eighty":-3.582346,"marketCap":697753915},{"date":"2025-05-02","current":-3.252786,"twenty":-16.791042,"median":-7.279839,"eighty":-3.541256,"marketCap":742422488},{"date":"2025-05-09","current":-2.6218,"twenty":-16.791042,"median":-7.234737,"eighty":-3.513106,"marketCap":598404848},{"date":"2025-05-16","current":-2.43959,"twenty":-16.777387,"median":-7.178793,"eighty":-3.476302,"marketCap":556816866},{"date":"2025-05-23","current":-2.730643,"twenty":-16.657668,"median":-7.147348,"eighty":-3.456269,"marketCap":675279930},{"date":"2025-05-30","current":-2.920791,"twenty":-16.652724,"median":-7.131505,"eighty":-3.437637,"marketCap":722302847},{"date":"2025-06-06","current":-3.039244,"twenty":-16.636006,"median":-7.108524,"eighty":-3.417157,"marketCap":751595812},{"date":"2025-06-13","current":-3.081325,"twenty":-16.625774,"median":-7.092688,"eighty":-3.377634,"marketCap":762002523},{"date":"2025-06-20","current":-2.958197,"twenty":-16.627754,"median":-7.067232,"eighty":-3.325896,"marketCap":731553257},{"date":"2025-06-27","current":-2.948846,"twenty":-16.544737,"median":-7.037548,"eighty":-3.285474,"marketCap":729240655},{"date":"2025-07-03","current":-2.930143,"twenty":-16.498817,"median":-7.021479,"eighty":-3.248209,"marketCap":724615450},{"date":"2025-07-11","current":-3.357195,"twenty":-16.442084,"median":-6.999592,"eighty":-3.235625,"marketCap":830224297},{"date":"2025-07-18","current":-3.896466,"twenty":-16.364758,"median":-6.976101,"eighty":-3.235625,"marketCap":963584375},{"date":"2025-07-25","current":-0.966324,"twenty":-16.32862,"median":-6.95293,"eighty":-3.220261,"marketCap":238968925},{"date":"2025-08-01","current":-2.211852,"twenty":-16.32862,"median":-6.926755,"eighty":-3.197708,"marketCap":546984433},{"date":"2025-08-08","current":-1.521613,"twenty":-16.25891,"median":-6.884333,"eighty":-3.189052,"marketCap":426383313},{"date":"2025-08-15","current":-1.490264,"twenty":-16.251257,"median":-6.855232,"eighty":-3.157696,"marketCap":417598776},{"date":"2025-08-22","current":-1.559902,"twenty":-16.251257,"median":-6.81724,"eighty":-3.102781,"marketCap":437112737},{"date":"2025-08-29","current":-1.498621,"twenty":-16.22547,"median":-6.802605,"eighty":-3.090882,"marketCap":419940451},{"date":"2025-09-05","current":-1.618399,"twenty":-16.215929,"median":-6.784969,"eighty":-3.068883,"marketCap":453504465},{"date":"2025-09-12","current":-1.67411,"twenty":-16.132635,"median":-6.773685,"eighty":-3.048595,"marketCap":469115634},{"date":"2025-09-19","current":-0.963797,"twenty":-16.075902,"median":-6.738316,"eighty":-3.021518,"marketCap":270073227},{"date":"2025-09-26","current":-1.128144,"twenty":-16.075902,"median":-6.70973,"eighty":-2.979471,"marketCap":316126176},{"date":"2025-10-03","current":-1.295276,"twenty":-16.070745,"median":-6.676586,"eighty":-2.957539,"marketCap":362959683},{"date":"2025-10-10","current":-1.289705,"twenty":-15.972753,"median":-6.634349,"eighty":-2.934568,"marketCap":361398566},{"date":"2025-10-17","current":-1.300847,"twenty":-15.720035,"median":-6.618272,"eighty":-2.911439,"marketCap":364520800},{"date":"2025-10-24","current":-2.345425,"twenty":-15.642673,"median":-6.590111,"eighty":-2.877151,"marketCap":657230223},{"date":"2025-10-31","current":-2.855179,"twenty":-15.609575,"median":-6.559251,"eighty":-2.844036,"marketCap":800072421},{"date":"2025-11-07","current":-2.138427,"twenty":-15.549838,"median":-6.518465,"eighty":-2.766893,"marketCap":663474691},{"date":"2025-11-14","current":-2.2704,"twenty":-15.403136,"median":-6.4784,"eighty":-2.692322,"marketCap":704421139},{"date":"2025-11-21","current":-2.277985,"twenty":-15.271334,"median":-6.451122,"eighty":-2.648794,"marketCap":706774439},{"date":"2025-11-28","current":-2.561153,"twenty":-15.219759,"median":-6.429475,"eighty":-2.625584,"marketCap":794630973},{"date":"2025-12-05","current":-2.662284,"twenty":-14.946412,"median":-6.40352,"eighty":-2.620854,"marketCap":826008307},{"date":"2025-12-12","current":-2.495417,"twenty":-13.958066,"median":-6.383313,"eighty":-2.604134,"marketCap":774235706},{"date":"2025-12-19","current":-2.449908,"twenty":-13.596799,"median":-6.36048,"eighty":-2.596346,"marketCap":760115906},{"date":"2025-12-26","current":-2.55104,"twenty":-13.291832,"median":-6.338592,"eighty":-2.58465,"marketCap":791493240},{"date":"2026-01-02","current":-2.457493,"twenty":-13.118236,"median":-6.327267,"eighty":-2.573794,"marketCap":762469206},{"date":"2026-01-09","current":-2.080779,"twenty":-12.963407,"median":-6.307407,"eighty":-2.55104,"marketCap":645588638},{"date":"2026-01-16","current":-1.845648,"twenty":-12.714743,"median":-6.285013,"eighty":-2.534069,"marketCap":572636338},{"date":"2026-01-23","current":-1.997345,"twenty":-12.311249,"median":-6.235116,"eighty":-2.528285,"marketCap":619702338},{"date":"2026-01-30","current":-1.868403,"twenty":-11.211732,"median":-6.162507,"eighty":-2.517403,"marketCap":579696238},{"date":"2026-02-06","current":-1.817446,"twenty":-11.019024,"median":-6.148507,"eighty":-2.510177,"marketCap":572228249},{"date":"2026-02-13","current":-2.092816,"twenty":-10.814754,"median":-6.110597,"eighty":-2.497946,"marketCap":658929499},{"date":"2026-02-20","current":-2.242303,"twenty":-10.706838,"median":-6.07878,"eighty":-2.482776,"marketCap":705995892},{"date":"2026-02-27","current":-2.016762,"twenty":-10.556526,"median":-6.058002,"eighty":-2.458949,"marketCap":634983440},{"date":"2026-03-06","current":-1.846294,"twenty":-10.40236,"median":-6.036439,"eighty":-2.442323,"marketCap":581311237},{"date":"2026-03-13","current":-1.987913,"twenty":-10.248194,"median":-5.978062,"eighty":-2.420917,"marketCap":625900452},{"date":"2026-03-20","current":-1.806955,"twenty":-10.117153,"median":-5.91342,"eighty":-2.412145,"marketCap":568925344},{"date":"2026-03-27","current":-1.977423,"twenty":-9.978403,"median":-5.880889,"eighty":-2.397739,"marketCap":622597547},{"date":"2026-04-02","current":-1.995781,"twenty":-9.924445,"median":-5.830805,"eighty":-2.391192,"marketCap":628377630},{"date":"2026-04-10","current":-1.549943,"twenty":-9.665081,"median":-5.656786,"eighty":-2.37406,"marketCap":488004178},{"date":"2026-04-17","current":-0.574344,"twenty":-9.087991,"median":-5.234053,"eighty":-2.347166,"marketCap":180834035},{"date":"2026-04-24","current":-0.747434,"twenty":-8.83037,"median":-5.064832,"eighty":-2.334988,"marketCap":235331964},{"date":"2026-05-01","current":-0.674002,"twenty":-8.731415,"median":-4.967292,"eighty":-2.311998,"marketCap":212211630},{"date":"2026-05-08","current":-0.875941,"twenty":-8.613496,"median":-4.909491,"eighty":-2.308324,"marketCap":275792547},{"date":"2026-05-15","current":-1.29293,"twenty":-8.5142,"median":-4.792197,"eighty":-2.28557,"marketCap":407083011},{"date":"2026-05-22","current":-1.368985,"twenty":-8.410027,"median":-4.717215,"eighty":-2.272928,"marketCap":431029071},{"date":"2026-05-29","current":-1.227366,"twenty":-8.239582,"median":-4.649393,"eighty":-2.265382,"marketCap":386439856},{"date":"2026-06-05","current":-2.588483,"twenty":-8.15628,"median":-4.618503,"eighty":-2.265906,"marketCap":814991749},{"date":"2026-06-12","current":-2.260661,"twenty":-8.100229,"median":-4.551876,"eighty":-2.260895,"marketCap":711775975},{"date":"2026-06-18","current":-2.622577,"twenty":-8.053709,"median":-4.522151,"eighty":-2.260895,"marketCap":825726190},{"date":"2026-06-26","current":-2.918928,"twenty":-7.99007,"median":-4.429773,"eighty":-2.260848,"marketCap":919033249},{"date":"2026-07-02","current":-3.000142,"twenty":-7.963496,"median":-4.387332,"eighty":-2.260848,"marketCap":941864706},{"date":"2026-07-10","current":-2.970729,"twenty":-7.901087,"median":-4.30245,"eighty":-2.260848,"marketCap":932630738},{"date":"2026-07-17","current":-2.545575,"twenty":-7.845639,"median":-4.253208,"eighty":-2.260848,"marketCap":799157932},{"date":"2026-07-24","current":-2.796924,"twenty":-7.809529,"median":-4.134455,"eighty":-2.260848,"marketCap":878066384},{"date":"2026-07-31","current":-1.446921,"twenty":-7.7639,"median":-4.046085,"eighty":-2.258937,"marketCap":454246424},{"date":"2026-08-07","current":-3.439447,"twenty":-7.691772,"median":-3.943811,"eighty":-2.258937,"marketCap":1079779856},{"date":"2026-08-14","current":-4.535012,"twenty":-7.658502,"median":-3.936989,"eighty":-2.258937,"marketCap":1423721651},{"date":"2026-08-21","current":-4.456996,"twenty":-7.642831,"median":-3.936989,"eighty":-2.258937,"marketCap":1323785857},{"date":"2026-08-28","current":-4.948693,"twenty":-7.558156,"median":-3.936989,"eighty":-2.258937,"marketCap":1469826290},{"date":"2026-09-04","current":-4.850354,"twenty":-7.479696,"median":-3.936989,"eighty":-2.258937,"marketCap":1440618203},{"date":"2026-09-10","current":-4.583886,"twenty":-7.444915,"median":-3.936989,"eighty":-2.258937,"marketCap":1361473711}],"updateTime":1789141094220},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REPL\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640498683","title":"Replimune presents 3-year overall survival data from IGNYTE trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640498683","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640498683?lang=en_us&edition=fundamental","pubTime":"2026-06-01 04:35","pubTimestamp":1780259704,"startTime":"0","endTime":"0","summary":"Replimune (REPL) Group presented 3-year landmark overall survival data from the IGNYTE clinical trial of RP1 plus nivolumab in patients with anti-P...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-presents-3-year-overall-survival-data-from-ignyte-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-presents-3-year-overall-survival-data-from-ignyte-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639988502","title":"Replimune publishes RP2 Phase 1 ASCO presentation data###","url":"https://stock-news.laohu8.com/highlight/detail?id=2639988502","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639988502?lang=en_us&edition=fundamental","pubTime":"2026-05-31 20:22","pubTimestamp":1780230152,"startTime":"0","endTime":"0","summary":"Replimune published final Phase 1 first-in-human results for RP2, an intratumoral oncolytic HSV-1 immunotherapy, alone or with nivolumab.Safety profile described as well tolerated, with no unexpected toxicity in the nivolumab combination; no grade 4-5 treatment-related adverse events reported.Objective response rate was 19% on RP2 monotherapy  versus 19.1% on RP2 plus nivolumab ; disease control 42.9% versus 48.9%.Median duration of response was not reached on monotherapy; 22.1 months on combination therapy, supporting durability in heavily pretreated solid tumors.Program advanced into a randomized Phase 2/3 trial of RP2 plus nivolumab in metastatic uveal melanoma .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. pu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nNDL2RCh4F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639988531","title":"Replimune says RP2 plus nivolumab posts 19.1% response rate in phase 1 advanced solid tumor trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2639988531","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639988531?lang=en_us&edition=fundamental","pubTime":"2026-05-31 20:00","pubTimestamp":1780228829,"startTime":"0","endTime":"0","summary":"Replimune presented final first-in-human Phase 1 data for RP2, alone or with nivolumab, in advanced solid tumors at the 2026 ASCO meeting.Results showed tumor shrinkage in a meaningful share of heavily pretreated patients, with responses lasting for extended periods in some cases.Activity was seen beyond injected tumors, supporting a broader immune effect that could expand RP2’s addressable use across metastatic disease.Safety looked consistent with expectations, with no unexpected severe treatment-related events reported.The readout supports a randomized Phase 2/3 study of RP2 with nivolumab in metastatic uveal melanoma .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nNDL6VsxYq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKPKM429.USD","NDAQ","BK4112","IE00BN0W2W23.USD","LU2095319765.USD","IE00BGHQF748.EUR","BK4588","REPL","IE00BN0W2V16.EUR","SG9999014039.USD","LU2210150020.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","LU0314104364.USD","LU2210149790.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639569988","title":"Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639569988","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639569988?lang=en_us&edition=fundamental","pubTime":"2026-05-31 20:00","pubTimestamp":1780228800,"startTime":"0","endTime":"0","summary":"WOBURN, Mass., May  31, 2026  (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today pres","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/31/3303918/0/en/Replimune-Presents-Final-First-in-Human-Data-for-RP2-in-Advanced-Solid-Tumors-During-Oral-Presentation-at-the-2026-American-Society-of-Clinical-Oncology-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","MAGE","IE00B19Z4B17.USD","REPL","BK4157","IE0031619046.USD","BK4139","BK4107","AEIS","ORR","IE00B7SZL793.SGD","LU0757428866.USD","IE00B66KJ199.SGD","BK4117","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639660951","title":"Replimune Group - Rp1 Plus Nivolumab Achieves Median Overall Survival of 32.9 Months in Anti-Pd-1-Failed Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2639660951","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639660951?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:10","pubTimestamp":1780143001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nFWN42615I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639095816","title":"Replimune reports 32.9-month median survival in IGNYTE trial of RP1-nivolumab in anti-PD-1-failed melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2639095816","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639095816?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142450,"startTime":"0","endTime":"0","summary":"Replimune presented 3-year overall survival follow-up from IGNYTE at the 2026 ASCO annual meeting on May 30.RP1 with nivolumab showed durable survival in advanced melanoma patients whose disease progressed on prior anti-PD-1 therapy.Benefit appeared sustained in long-term responders, supporting the regimen’s potential to extend disease control in a hard-to-treat setting.Safety remained manageable over extended follow-up, with no new safety concerns flagged in the update.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nNDL1xGNnt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BKPKM429.USD","NDAQ","SG9999014021.USD","LU0314104364.USD","BK4112","BK4588","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4139","SG9999014013.SGD","IE00BN0W2W23.USD","LU2095319765.USD","IE00B64PRP62.GBP","REPL","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","SG9999014039.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639609563","title":"Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639609563","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639609563?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142400,"startTime":"0","endTime":"0","summary":"WOBURN, Mass., May  30, 2026  (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today pres","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/30/3303875/0/en/Replimune-Presents-3-Year-Landmark-Overall-Survival-Analysis-from-IGNYTE-Clinical-Trial-During-Oral-Presentation-at-the-2026-American-Society-of-Clinical-Oncology-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORR","LARK","REPL","AFG","BK4107","BK4211","BK4117","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639124677","title":"Top News Today: Stocks Rise as Traders Await Iran Deal Confirmation","url":"https://stock-news.laohu8.com/highlight/detail?id=2639124677","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639124677?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:45","pubTimestamp":1780087500,"startTime":"0","endTime":"0","summary":"TREASURYS: Treasury yields were mostly lower as traders weighed mixed economic data and developments in the Middle East.COMMODITIES: Oil futures fell, completing their biggest monthly net decline in New York since March 2020.Universal Music Group Rejects $65 Billion Buyout Offer From Bill Ackman. UMG's board of directors assessed Pershing Square's unsolicited offer and found that it \"fundamentally and materially undervalues UMG and will not deliver superior value creation.\". \"UMG has built an unrivalled position in the music industry through clear vision and execution,\" said board Chairman Sherry Lansing in a statement, adding that the board has \"full confidence\" in Chief Executive Lucian Grainge and his team.Trump Administration Wants Autos Under USMCA to Be at Least 50% Made in America. International Flavors & Fragrances has agreed to sell its food-ingredients business to buyout firm CVC Capital Partners in a deal that values the division at $","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B775H168.HKD","LU0306807586.USD","LU0912757837.SGD","LU0211326839.USD","LU1267930730.SGD","LU0011850046.USD","LU0211328371.USD","BK4141","LU0128525689.USD","BK4534","SG9999014880.SGD","IE00B19Z3581.USD","SGXZ31699556.SGD","LU0553294199.USD","LU2271345857.HKD","IE0002141913.USD","LU1791710400.SGD","LU2237438978.USD","BK4585","LU0006061336.USD","LU0314106906.USD","LU0742534661.SGD","LU2360107168.USD","SG9999002224.SGD","LU0266013472.USD","LU0094547139.USD","LU0109391861.USD","LU0545039389.USD","LU1720051108.HKD","LU0985481810.HKD","LU0321505439.SGD","LU0795875169.SGD","LU1496350502.SGD","LU1934455863.HKD","LU1035773651.USD","LU2360032135.SGD","LU0211327993.USD","IE00BFTCPJ56.SGD","LU0719512351.SGD","SG9999018857.SGD","LU2236285917.USD","LU1267930573.SGD","LU2133065610.SGD","IE00B7SZLL34.SGD","IE00B19Z9Z06.USD","IE00B894F039.SGD","LU2468319806.SGD","SG9999017495.SGD","IE00BN29S564.USD","LU2461242641.AUD","LU1037948541.HKD","IE00BJJMRZ35.SGD","IE00BJJMRY28.SGD","LU2362540622.SGD","SGXZ81514606.USD","LU0251142724.SGD","SGXZ51526630.SGD","IFF","SGXZ57979304.SGD","IE0005OL40V9.USD","LU0861579265.USD","LU0345770308.USD","LU1670628061.USD","LU2242649171.HKD","LU2362541273.HKD","LU1119994496.HKD","BK4504","IE00BKVL7J92.USD","LU2347655156.SGD","IE00B2B36J28.USD","CRDO","LU0082616367.USD","LU1069347547.HKD","LU1674673691.USD","LU1037948897.HKD","LU0053666078.USD","LU0048584097.USD","LU2087625088.SGD","LU0149725797.USD","LU1506573853.SGD","LU0198837287.USD","LU1720051017.SGD","IE00BFSS8Q28.SGD","LU1551013425.SGD","IE0004445239.USD","LU1732799900.SGD","LU1064131342.USD","IE00BKPKM429.USD","LU0211326755.USD","LU2125154935.USD","LU0289739699.SGD","LU0348723411.USD","LU0557290698.USD","BK4109","LU0820562030.AUD","LU0985320562.USD","LU1261432733.SGD","BK4007","LU0320765059.SGD","LU1548497426.USD","BK4533","BK4170","LU0238689110.USD","LU0456855351.SGD","LU1934455194.USD","IE00B4R5TH58.HKD","LU2361045086.USD","LU0965509101.SGD","LU0158827781.USD","LU0820561909.HKD","LU1057294990.SGD","SG9999014898.SGD","LU0203345920.USD","LU0114720955.EUR","LU1861220033.SGD","LU0107464264.USD","IE00B19Z9505.USD","SG9999014914.USD","LU2491050071.SGD","LU2552382132.HKD","LU0354030438.USD","LU1778281490.HKD","BK4561","LU0820561818.USD","LU0310800379.SGD","LU0353189680.USD","BK4566","IE00B19Z3B42.SGD","LU2491050154.USD","LU0496365809.HKD","SG9999014906.USD","BK4581","IE0002270589.USD","LU0225771236.USD","LU0345770993.USD","LU0417517546.SGD","LU1066051225.USD","LU2264538146.SGD","LU1084165304.USD","BK4139","LU0787776722.HKD","LU1267930490.SGD","BK4156","LU2089284900.SGD","LU0306806265.USD","LU0354030511.USD","UEC","LU0708995401.HKD","LU2023251221.USD","LU1854104046.USD","LU2111349929.HKD","BK4588","LU1791710582.SGD","IE00BJJMRX11.SGD","LU1291159041.SGD","LU0128525929.USD","LU2028103732.USD","LU2552382058.USD","IE00B7KXQ091.USD","SGXZ99366536.SGD","LU0882574055.USD","IE0009354923.USD","IE00B1XK9C88.USD","LU0672654240.SGD","LU0949170772.SGD","CRDU","LU2089984988.USD","IE0004445015.USD","LU0079474960.USD","LU0122379950.USD","UECG","HPE","IE0009355771.USD","LU2361044949.HKD","LU0342679015.USD","LU0058720904.USD","LU1988902786.USD","LU1989771016.USD","IE00B4JS1V06.HKD","SG9999013999.USD","UNHW","IE00BJT1NW94.SGD","BK4532","LU0353189763.USD","LU2211815571.USD","LU0689472784.USD","LU0052756011.USD","LU0158827948.USD","LU0203347892.USD","SG9999002232.USD","IE00BZ1G4Q59.USD","LU2244417387.USD","LU1814569148.SGD","LU0708994859.HKD","LU1323610961.USD","BK4123","LU1674673428.USD","LU2324357040.USD","LU0029864427.USD","IE00BFSS7M15.SGD","LU1861215975.USD","LU0097036916.USD","LU0823416689.USD","LU1153585028.USD","LU2361044865.SGD","LYRA","IE00BZ9MQY76.HKD","LU0943347566.SGD","UNHG","SG9999001176.USD","BK4606","LU0738911758.USD","LU0976567544.SGD","IE00BWXC8680.SGD","LU2125154778.USD","LU2362541513.USD","SAIC","REPL","LU2552382215.SGD","LU0187121727.USD","LU1061106388.HKD","LU2357305700.SGD","LU1670627923.USD","LU2089283258.USD","LU0053671581.USD","LU1003077747.HKD","LU0965509010.AUD","LU0048573561.USD","IE000M9KFDE8.USD","LU0256863811.USD","LU0077335932.USD","BK4515","LU0316494557.USD","LU1066051811.HKD","LU0251132253.USD","LU0321505868.SGD","IE00BSNM7G36.USD","LU0683600562.USD","LU1066053197.SGD","LU1732800096.USD","LU1854103824.USD","LU2290526834.HKD","LU0251131958.USD","LU0234572021.USD","LU1074936037.SGD","LU1983299246.USD","BK4154","LU2112291526.USD","LU0965509283.SGD","IE00BFXG1179.USD","LU2491049909.HKD","LU0225284248.USD","LU2279689827.SGD","LU1914381329.SGD","LU1551013342.USD","LU0432979614.USD","IE00B19Z8X17.USD","LU0528227936.USD","IE00B19Z9P08.USD","LU0310800965.SGD","LU1023059063.AUD","LU0310799852.SGD","LU1066051498.USD","LU1267930227.SGD","SG9999001176.SGD","SG9999018865.SGD","LU0965508806.USD","LU0795875086.SGD","UNH","LU0661504455.SGD","IE00B19Z8W00.USD","LU1718418525.SGD","IE00B1BXHZ80.USD","LU1934455277.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639794546","title":"Wedbush Adjusts Price Target on Replimune Group to $6 From $2, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2639794546","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639794546?lang=en_us&edition=fundamental","pubTime":"2026-05-30 00:25","pubTimestamp":1780071959,"startTime":"0","endTime":"0","summary":"Replimune Group (REPL) has an average rating of underweight and mean price target of $2.20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639679910","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2639679910","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639679910?lang=en_us&edition=fundamental","pubTime":"2026-05-30 00:17","pubTimestamp":1780071462,"startTime":"0","endTime":"0","summary":"NetApp  reported fiscal Q4 non-GAAP earnings and revenue late Thursday above market expectations, and its forecast for the full financial year also beat consensus.Shares soared 27% amid a surge in intraday trading volume to over 6.5 million from a daily average of roughly 2.5 million.Dell Technologies  reported overnight fiscal Q1 financial results that topped analyst estimates and issued higher-than-expected guidance for fiscal Q2 and the full year.Shares surged 29% as intraday trading volume catapulted to over 27.1 million from a daily average of about 7.99 million.Replimune  said Friday it will, in the coming days, resubmit a biologics license application with the US Food and Drug Administration for vusolimogene oderparepvec, its experimental treatment for advanced melanoma.Shares catapulted 83% following an increase in intraday trading volume to over 39.8 million from a daily average of about 6.19 million.Price: 180.63, Change: +38.23, Percent Change: +26.85","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4535","LU0267386448.USD","LU0496365809.HKD","LU0310800965.SGD","LU0868494708.USD","SG9999001440.SGD","LU1235294995.USD","BK4588","LU0203345920.USD","NTAP","BK4139","BK4585","BK4515","LU1823568750.SGD","LU0203347892.USD","BK4543","LU2065171311.SGD","LU0976567544.SGD","DLLL","LU1046421795.USD","LU0211326839.USD","LU1267930227.SGD","LU0128525689.USD","LU0868494617.USD","BK4170","LU0052756011.USD","LU0942090050.USD","LU2065171402.SGD","DELL","LU2065170008.USD","LU0211326755.USD","REPL","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639267579","title":"Why Penny Stock Replimune (REPL) Nearly Doubled Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2639267579","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639267579?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:55","pubTimestamp":1780066513,"startTime":"0","endTime":"0","summary":"Shares of Replimune ($REPL) are surging today after the biotech company announced that it plans to resubmit its melanoma drug RP1 for FDA approval ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-penny-stock-replimune-repl-nearly-doubled-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-penny-stock-replimune-repl-nearly-doubled-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REPL","LABU","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151983558","title":"Replimune Shares Soar as FDA Reverses Course on Skin Cancer Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1151983558","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151983558?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:40","pubTimestamp":1780065627,"startTime":"0","endTime":"0","summary":"On Friday, shares of Replimune Group Inc. (REPL.US) surged dramatically, gaining over 77% to trade at $8.27. The surge followed the company's announcement that it has reached an agreement with the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4585","REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639667897","title":"Replimune Shares Surge 75% After Co Plans to Resubmit US Application for Skin Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2639667897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639667897?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:41","pubTimestamp":1780062119,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nFWN426144:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639620012","title":"BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, Replimune","url":"https://stock-news.laohu8.com/highlight/detail?id=2639620012","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639620012?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:21","pubTimestamp":1780060878,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, ReplimuneWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL6N4260OV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125154935.USD","BK4543","LU2210149790.SGD","GAP","IE00BZ1G4Q59.USD","LU0471298694.HKD","LU1066051811.HKD","LU1823568750.SGD","BK4182","BK4564","BK4581","COSW","LU0052756011.USD","LU0314106906.USD","LU1923622614.USD","LU2237438978.USD","LU2097829019.USD","LU0742534661.SGD","LU2125909593.SGD","REPL","BK4561","LU0234572021.USD","LU2125154778.USD","LU0128525689.USD","TEM","IFF","BK4170","AEO","BK4129","LU0385154629.USD","LU2065171311.SGD","LU0234570918.USD","LU2125909247.SGD","LU1551013342.USD","FLY","BK4613","BK4094","BK4515","BK4155","LU1323610961.USD","LU2065170008.USD","FPS","LU1066053197.SGD","LU2168564149.EUR","LU2433249047.HKD","BK4504","LU1035775433.USD","LU2168564495.EUR","LU0496365809.HKD","LU1116320901.HKD","LU2065169927.USD","LU1046421795.USD","BK4550","BK4615","BK4139","COST","BK4588","LU1235294995.USD","LU0823434583.USD","LU0471298777.SGD","LUNL","BK4123","LU1066051498.USD","LU2360106947.USD","LU1066051225.USD","LU1116320737.USD","LU0976567544.SGD","DELL","BK4121","LU0689472784.USD","IE0008368304.USD","LU2168564222.USD","LU1069344957.HKD","LU1861559042.SGD","BK4585","BK4602","LU0943347566.SGD","LU0211326755.USD","IE00BKVL7J92.USD","LU0985320562.USD","HK0000819398.USD","LU0211326839.USD","LU0256863811.USD","FLYT","LU0251131958.USD","BK4109","BK4611","RKLB","LU0048573561.USD","LU1861558580.USD","LU2065171402.SGD","AGIO","LU1267930227.SGD","LU1506573853.SGD","LU0267386448.USD","LU2360032135.SGD","PL","TEMT","LU0265550946.USD","UFO","BK4533","LU1551013425.SGD","LU0251142724.SGD","LU0079474960.USD","LU0820561909.HKD","MWH","COTG","LU2210150020.SGD","IE00B5TLWC47.USD","LU0238689110.USD","LU1496350502.SGD","LU2095319765.USD","LU0310800965.SGD","KRMN","LU2168564065.EUR","RKLZ","LU0823434740.USD","RKLX","LU1496350171.SGD","BK4596","LUNR","BK4535","LU2381873111.SGD","DLLL","LU2168563687.JPY","LU0820561818.USD","LU0265550359.USD","PLU","BK4187","LU1571399168.USD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639275466","title":"Market Chatter: Replimune Plans to Resubmit Melanoma Therapy Application for FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2639275466","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639275466?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:21","pubTimestamp":1780057313,"startTime":"0","endTime":"0","summary":"Replimune (REPL) is planning in the coming days to resubmit a new application with the US Food and Drug Administration for its experimental advanced melanoma treatment, The Wall Street Journal reporte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","BK4139","REPL","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639627345","title":"Replimune Gets Third Try at FDA Approval After Makary Departure -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2639627345","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639627345?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:19","pubTimestamp":1780057140,"startTime":"0","endTime":"0","summary":"Replimune Group said Friday it has reached an agreement with the Food and Drug Administration on a path to resubmit its application for its experimental treatment for advanced melanoma.It wasn't immediately clear whether Replimune would submit new clinical data or additional analyses of existing trial results to help secure approval.The company plans to resubmit the application in the coming days, the company said. Replimune shares were up more than 70% in premarket trading.The move marks a sharp reversal for a drug that became one of the most contentious rejections for the agency under the leadership of former FDA Commissioner Marty Makary and illustrates how quickly priorities are shifting in the agency in the wake of the commissioner's departure earlier this month.The FDA twice rejected Replimune's application for approval, first in July 2025 and again in April, saying the data from a single-arm trial, in which all patients received the experimental drug with no comparison group, fe","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639731622","title":"Replimune plans RP1 melanoma BLA resubmission after FDA talks","url":"https://stock-news.laohu8.com/highlight/detail?id=2639731622","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639731622?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:05","pubTimestamp":1780056322,"startTime":"0","endTime":"0","summary":"Replimune plans to resubmit its RP1 biologics license application for advanced melanoma in the coming days following FDA discussions.The FDA signaled it will treat the resubmission as urgent and prioritize the review once received.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published the original content used to generate this news brief on May 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL3cHcNm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639234622","title":"Replimune reaches agreement with US FDA to resubmit melanoma drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2639234622","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639234622?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:03","pubTimestamp":1780056220,"startTime":"0","endTime":"0","summary":"Replimune reaches agreement with US FDA to resubmit melanoma drug applicationMay 29  - Replimune REPL.O said on Friday it it has reached an agreement with the U.S. Food and Drug Administration to resubmit the marketing application for its experimental skin cancer drug after the regulator twice declined to approve the therapy.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL4N42612P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639622900","title":"Replimune Announces Planned Rp1 Bla Resubmission Following Productive Discussion With FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2639622900","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639622900?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUA3QZZ6G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639622139","title":"Replimune Group - to Resubmit Rp1 Bla for Advanced Melanoma After Alignment With FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2639622139","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639622139?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUA3QZZ6G:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":190,"code":"91000000","status":"200"}]}}